Scientists test tracer to see Cells' 'Battery' in real time
NCT ID NCT07506616
First seen Apr 18, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This early study tests a new radioactive tracer called 18F-TPP to see if it can map the energy levels inside cells using PET scans. Researchers will study 24 healthy adults to understand how the tracer moves through the body and develop methods to measure cell membrane potential. This is a first step toward better imaging of cell health, not a treatment study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMBRANE POTENTIAL MAPPING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale University PET Center
New Haven, Connecticut, 06510, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-TPP (a radioactive tracer for PET imaging)
What this could lead to
If successful, this could provide a new way to see cell health in the body, which may help study diseases like heart or brain conditions.
What could go wrong
This is a very early Phase 1 study with only 24 healthy volunteers. It is designed to test the imaging method, not to treat any illness, so it may not lead to direct patient benefits.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.